Oncolytic adenoviruses were designed to reach potent intratumoral T-cell activation via expression of bifunctional-T-cell ...
Novel CD37 antibody-drug conjugate shows promise in targeting the Achilles’ heel of acute myeloid leukemia cells.
Treatment options for patients with esophageal squamous cell carcinoma (ESCC) often result in poor prognosis and declining ...